Table 1

Laboratory and clinical features of the patients

Patient	Age/Sex	Bleeding symptoms	Associated disorders	Platelet (×10⁹/l)	Bleeding time	Ristocetin	ADP (2μM)	ADP (10µM)	Collagen (2µM)	Epinephrine (10 µM)	ATP release (2 µM ADP)	ATP release (10 µM ADP)
CRF, chronic renal failure; EPO, erythropoietin (chronic anaemia); m, months; N, normal; ND, not done; y, years.
1	7y/M	Present	CRF, EPO responsive anaemia, hepatomegaly	236	19 min	N	Reduced primary aggregation	Minimal improvement	Reduced primary aggregation	Reduced primary aggregation	Absent	Minimal
2	1y 6m/M	Absent	None	406	9 min	N	Absent secondary aggregation	N	N	N	ND*	ND*
3	1 y/F	Absent	None	217	25 min	N	Absent secondary aggregation	Minimal improvement	N	Reduced secondary aggregation	Absent	Minimal
4	3y 6m/M	Absent	None	510	9 min 30 s	N	N	N	N	N	N	N
5	2y 6m/M	Absent	None	232	15 min 7 s	N	Absent secondary aggregation	Minimal improvement	N	Absent secondary aggregation	ND	ND
6	9y 8m/M	Present	CRF	257	21 min	N	Absent secondary aggregation	ND	N	ND*	ND*	ND*
7	5y 9m/M	Absent	None	300	4 min 30 s	N	N	N	N	ND*	ND*	ND*